Literature DB >> 12454011

Enzymatic and structural analysis of inhibitors designed against Mycobacterium tuberculosis thymidylate kinase. New insights into the phosphoryl transfer mechanism.

Ahmed Haouz1, Veerle Vanheusden, Hélène Munier-Lehmann, Mattheus Froeyen, Piet Herdewijn, Serge Van Calenbergh, Marc Delarue.   

Abstract

The chemical synthesis of new compounds designed as inhibitors of Mycobacterium tuberculosis TMP kinase (TMPK) is reported. The synthesis concerns TMP analogues modified at the 5-position of the thymine ring as well as a novel compound with a six-membered sugar ring. The binding properties of the analogues are compared with the known inhibitor azido-TMP, which is postulated here to work by excluding the TMP-bound Mg(2+) ion. The crystallographic structure of the complex of one of the compounds, 5-CH(2)OH-dUMP, with TMPK has been determined at 2.0 A. It reveals a major conformation for the hydroxyl group in contact with a water molecule and a minor conformation pointing toward Ser(99). Looking for a role for Ser(99), we have identified an unusual catalytic triad, or a proton wire, made of strictly conserved residues (including Glu(6), Ser(99), Arg(95), and Asp(9)) that probably serves to protonate the transferred PO(3) group. The crystallographic structure of the commercially available bisubstrate analogue P(1)-(adenosine-5')-P(5)-(thymidine-5')-pentaphosphate bound to TMPK is also reported at 2.45 A and reveals an alternative binding pocket for the adenine moiety of the molecule compared with what is observed either in the Escherichia coli or in the yeast enzyme structures. This alternative binding pocket opens a way for the design of a new family of specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454011     DOI: 10.1074/jbc.M209630200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Mechanisms of substrate selectivity for Bacillus anthracis thymidylate kinase.

Authors:  Cecilia Carnrot; Liya Wang; Dimitri Topalis; Staffan Eriksson
Journal:  Protein Sci       Date:  2008-06-03       Impact factor: 6.725

2.  3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents.

Authors:  Carolina Horta Andrade; Kerly F M Pasqualoto; Elizabeth I Ferreira; Anton J Hopfinger
Journal:  J Comput Aided Mol Des       Date:  2010-03-10       Impact factor: 3.686

Review 3.  Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery.

Authors:  Zhiyong Lou; Xiaoxue Zhang
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

4.  Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.

Authors:  Vladimir Frecer; Pierfausto Seneci; Stanislav Miertus
Journal:  J Comput Aided Mol Des       Date:  2010-11-17       Impact factor: 3.686

5.  Structure-based in-silico rational design of a selective peptide inhibitor for thymidine monophosphate kinase of mycobacterium tuberculosis.

Authors:  Manoj Kumar; Sujata Sharma; Alagiri Srinivasan; Tej P Singh; Punit Kaur
Journal:  J Mol Model       Date:  2010-08-11       Impact factor: 1.810

6.  Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding.

Authors:  Masayo Kotaka; Balvinder Dhaliwal; Jingshan Ren; Charles E Nichols; Richard Angell; Michael Lockyer; Alastair R Hawkins; David K Stammers
Journal:  Protein Sci       Date:  2006-03-07       Impact factor: 6.725

7.  1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors.

Authors:  Yanlin Jian; Fabian Hulpia; Martijn D P Risseeuw; He Eun Forbes; Guy Caljon; Hélène Munier-Lehmann; Helena I M Boshoff; Serge Van Calenbergh
Journal:  Molecules       Date:  2020-06-17       Impact factor: 4.411

8.  Branched-chain C-cyano pyranonucleosides: synthesis of 3'-C-cyano & 3'-C-cyano-3'-deoxy pyrimidine pyranonucleosides as novel cytotoxic agents.

Authors:  Christos Kiritsis; Stella Manta; Vanessa Parmenopoulou; Jan Balzarini; Dimitri Komiotis
Journal:  Eur J Med Chem       Date:  2011-09-01       Impact factor: 6.514

9.  Bacterial Cytological Profiling Identifies Rhodanine-Containing PAINS Analogs as Specific Inhibitors of Escherichia coli Thymidylate Kinase In Vivo.

Authors:  Elizabeth T Montaño; Jason F Nideffer; Joseph Sugie; Eray Enustun; Adam B Shapiro; Hannah Tsunemoto; Alan I Derman; Kit Pogliano; Joe Pogliano
Journal:  J Bacteriol       Date:  2021-09-08       Impact factor: 3.490

10.  Design of Thymidine Analogues Targeting Thymidilate Kinase of Mycobacterium tuberculosis.

Authors:  Luc Calvin Owono Owono; Melalie Keita; Eugene Megnassan; Vladimir Frecer; Stanislav Miertus
Journal:  Tuberc Res Treat       Date:  2013-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.